Redirecting glucose flux during in vitro expansion generates epigenetically and metabolically superior T cells for cancer immunotherapy
Andrew Frisch(UPMC Hillman Cancer Center), Greg M. Delgoffe(University of Pittsburgh), Bingxian Xie(UPMC Hillman Cancer Center), Aaron Yang, Dayana B. Rivadeneira(University of Pittsburgh), Amanda C. Poholek(University of Pittsburgh), Victoria Dean(University of Pittsburgh), Konstantinos Lontos(The University of Texas MD Anderson Cancer Center), William Gunn(UPMC Hillman Cancer Center), Ronal M. Peralta(UPMC Hillman Cancer Center), Supriya Joshi(UPMC Hillman Cancer Center), Stacy G. Wendell(University of Pittsburgh), Drew N. Wilfahrt(UPMC Hillman Cancer Center), Katarzyna M. Kedziora(University of Pittsburgh), Kellie Spahr(UPMC Hillman Cancer Center), Yiyang Wang(University of Pittsburgh), Jessica A Jana(UPMC Hillman Cancer Center), Steven J. Mullett(University of Pittsburgh), B. Rhodes Ford(Children's Hospital of Pittsburgh)
Cited by 32
Related Papers
The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2
|Nature Immunology|2011|1.1k
4-1BB costimulation induces T cell mitochondrial function and biogenesis enabling cancer immunotherapeutic responses
|The Journal of Experimental Medicine|2018|302
In Vivo Regulation of Bcl6 and T Follicular Helper Cell Development
|The Journal of Immunology|2010|272
Hypoxia drives CD39-dependent suppressor function in exhausted T cells to limit antitumor immunity
|Nature Immunology|2022|254